Why don't you take a look at another company like IMGG?? Go look at what their stock did when they just mentioned filing for a 510(k), Their stock went to 1.90, and now their stock is .15 cents because the FDA shot them down. Now as you say, DIG DEEPER with IMGG, go look at their filings. They have less revenue than KLYG, more Debt, and look at their share structure !!!!!
They have 380,000,000 shares out !!!!! Their market cap is 60 times KLYG and they have less revenue, more debt etc. and the FDA shot them down.
Kelyniam is a dark horse in the back of the pack.
What Ketner is doing here is not running a pump. IF, IF, they get the FDA approval, and IF, they can produce 40 units a month by the end of 2011, the the stock is worth $3.85 per share at a P/E of 20. Bottom line, no pumping promotions, etc.
What if they can deliver 50 units a month, and say maybe 60?? You do the math.
KLYG has has a very tight share structure and the float is being held by strong investors. Don't believe me? go try and buy $5k worth KLYG stock right now. You'll be sitting at 30 cents a share.
Now go buy $50k of IMGG, No way that bohemith would move a penny
News 
Market Data 
Discover 
